IP Library Granted Patent US 11,186,559
Granted Patent B2
US 11,186,559 · App. 16/995,754 · Granted Nov 30, 2021

Methods for enriching alpha-tocotrienol from mixed tocol compositions

Inventors: Peter Giannousis (Pacifica, CA); Paul Mollard (San Jose, CA); Noah M. Benjamin (Rancho Cordova, CA); Jeffrey D. Butler (Rancho Cordova, CA); Olivier Dapremont (Rancho Cordova, CA); James B. Falabella (Rancho Cordova, CA)
Assignee: PTC Therapeutics, Inc.
C07D311/72
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,186,559
App. No.
16/995,754
Granted
Nov 30, 2021
Kind
B2
Abstract

Provided herein are methods for making an alpha-tocotrienol enriched tocol mixture, such as from a plant or plant-derived material. Also provided herein are simulated moving bed purification methods for tocotrienol compounds such as alpha tocotrienol.

Claims (37)

1. A method of purifying a tocotrienol from a feed solution comprising the steps of:

a. passing the feed solution through a chromatographic process comprising a stationary phase and a mobile phase stream, wherein said feed solution comprises the tocotrienol and one or more impurity compounds; and wherein the mobile phase stream comprises one or more solvents selected from acetonitrile, ethanol, and isopropyl alcohol;

b. operating the chromatographic process as a simulated moving bed (SMB) process under conditions effective to purify the tocotrienol from at least one impurity compound;

c. collecting a stream from the SMB apparatus, wherein said stream comprises the purified tocotrienol; and

d. repeating steps a.-c.; wherein the stream from the SMB apparatus is concentrated before its use as the feed solution in repeating steps a.-c.

2. The method of claim 1 , wherein the stream comprising the purified tocotrienol is an extract stream.

3. The method of claim 1 , wherein the stream comprising the purified tocotrienol is a raffinate stream.

4. The method of claim 1 , wherein the stream comprising the purified tocotrienol is the extract stream in a first pass, and wherein the stream comprising the purified tocotrienol is the raffinate stream in a second or subsequent pass.

5. The method of claim 1 , wherein the stream comprising the purified tocotrienol is the raffinate stream in a first pass, and wherein the stream comprising the purified tocotrienol is the extract stream in a second or subsequent pass.

6. The method of claim 1 , wherein the tocotrienol is selected from the group consisting of alpha-tocotrienol, beta-tocotrienol, delta-tocotrienol, and gamma-tocotrienol.

7. The method of claim 6 , wherein the tocotrienol is alpha-tocotrienol.

8. The method of claim 1 , wherein the stationary phase is selected from the group consisting of silica gel, functionalized silica gel, reverse phase gel, or chiral phase gel.

9. The method of claim 1 , wherein the stationary phase has a particle size of about 2 to about 300 μm.

10. The method of claim 1 , wherein the mobile phase stream further comprises one or more solvents selected from the group consisting of: water, t-AmOH, methanol, n-proposal, butanol, ethyl acetate, isopropyl acetate, MtBE, diethyl ether, fluorinated solvents, alkanes, hexanes, n-hexane, heptanes, n-heptane, methyl-cyclopentane, pentane, methyl-cyclohexane, cyclohexane, toluene, and CO 2 .

11. The method of claim 1 , wherein the mobile phase stream comprises acetonitrile.

12. The method of claim 1 , wherein the mobile phase stream comprises ethanol or isopropyl alcohol.

13. The method of claim 1 , wherein the alpha-tocotrienol in the feed stream is prepared according to a method for making an alpha-tocotrienol-enriched tocol mixture, comprising:

(a) contacting a tocol mixture with an amino-alkylating agent, wherein the tocol mixture comprises at least one non-alpha-tocotrienol, at least one non-tocol, optionally alpha-tocotrienol, and optionally one or more tocopherols, whereby the at least one non-alpha-tocotrienol is amino-alkylated;

(b) reducing the amino-alkylated non-alpha-tocotrienols to alpha-tocotrienol with a reducing agent;

(c) removing one or more waxy impurities from the mixture;

(d) contacting the mixture with an agent that binds one or more polar impurities; and

(e) removing the agent that binds one or more polar impurities.

14. The method of claim 1 , wherein a final product stream comprising purified tocotrienol comprises the tocotrienol with at least about 90 (A) % purity.

15. The method of claim 14 , wherein the final product stream comprising purified tocotrienol is concentrated to a tocotrienol concentration of at least about 90 wt %.

16. The method of claim 1 , wherein the chromatographic process comprises 2 to 30 columns serially connected.

17. The method of claim 1 , wherein the chromatographic process is operated at a rate of about 0.05 to about 5 kg feed stream per kg stationary phase per 24 hours.

18. The method of claim 1 , wherein the chromatographic process is operated at a pressure of about 2 bar to about 100 bar.

19. The method of claim 1 , wherein the chromatographic process is operated at a temperature of about 10° C. to about 50° C.

20. The method of claim 1 , wherein the stationary phase comprises a C 18 silica gel.

21. The method of claim 20 , wherein the stationary phase has a particle size from about 10 μm to about 25 μm.

22. The method of claim 3 , wherein the raffinate stream is collected and tocotrienol-containing fractions are subjected to a method for making an alpha-tocotrienol enriched tocol mixture, comprising:

(a) contacting a tocol mixture with an amino-alkylating agent, wherein the tocol mixture comprises at least one non-alpha-tocotrienol, at least one non-tocol, optionally alpha-tocotrienol, and optionally one or more tocopherols, whereby the at least one non-alpha-tocotrienol is amino-alkylated;

(b) reducing the amino-alkylated non-alpha-tocotrienols to alpha-tocotrienol with a reducing agent;

(c) removing one or more waxy impurities from the mixture;

(d) contacting the mixture with an agent that binds one or more polar impurities; and

(e) removing the agent.

23. The method of claim 10 , wherein the SMB method is run with two passes, with three passes, or with more than three passes.

Assignments (2)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT @ REEL 061803 AND FRAME 0878 Recorded Oct 20, 2023
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: PTC THERAPEUTICS, INC.
Reel/Frame 065303/0163 →
SECURITY INTEREST Recorded Oct 28, 2022
From: PTC THERAPEUTICS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 061803/0878 →